Please use this identifier to cite or link to this item:
http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/13926
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kushnir, O.V. | - |
dc.contributor.author | Sydorchuk, L.P. | - |
dc.contributor.author | Iftoda, O.M. | - |
dc.contributor.author | Sydorchuk, A.R. | - |
dc.date.accessioned | 2018-06-25T07:05:02Z | - |
dc.date.available | 2018-06-25T07:05:02Z | - |
dc.date.issued | 2015 | - |
dc.identifier.other | UDC 616.12-008.331.1:616.34-008.87 | - |
dc.identifier.uri | http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/13926 | - |
dc.description.abstract | Purpose. To establish the dependence of lipid profile changes in patients with essential arterial hypertension (EAH) on the type of left ventricular hypertrophy (LVH) and gene polymorphism of angiotensin-converting enzyme (ACE, I/D) and endothelial nitric oxide synthase (eNOS, T894G). Design/approach. In a prospective study 120 patients with EAH I-III severity stages: 12,5% (15) persons with EAH I, 60,0% (72) with EAH II, 27,5% (33) with EAH III; 48,3% (58) women and 51,7% (62) men, mean age 52,91±9,24, the disease duration from 2 to 28 years; the control group - 20 healthy individuals were involved. Ventricular mass (LVM) was evaluated by Echo-KG. Plasma lipids were studied by spectrophotometer, analyzed according to the recommendations of the ESC, ESH (2009). Genes' allele polymorphic areas of ACE (I/D), eNOS (T894G) were set by PCR analysis. Findings. High-risk groups of lipid profile changes in patients with EAH is a carriers of DD-genotype of ACE gene by increasing of low density cholesterol level and atherogenic index by 1,3 times (p<0,05). Genetic risk of dyslipidemia in EAH patients with unfavorable eccentric and concentric LVH and ACE and eNOS genes mutations (ID/TT, ID/ TG, DD/TG haplotypes) increases by 2,57-3,86 time (OR=2,57-3,86). Combination of Wild I-allele of ACE gene and G-allele of eNOS gene (II/GG, II/TG haplotypes) is protective against development of hypercholesterolemia in patients with unfavorable patterns of LVH (OR=0,12-0,94) and makes the chances of dyslipidemia risk the lowest in the population of EAH patients (p=0,05). Research limitations/implications. The study is limited by the peculiarities of laboratory and diagnostic tests. Originality/value. The original research without a prototype provides pathogenetic data for early detection and prevention of metabolic disorders in the presence/absence of LVH in patients with EAH. | ru_RU |
dc.language.iso | en | ru_RU |
dc.publisher | Клінічна та експериментальна патологія | ru_RU |
dc.subject | arterial hypertension | ru_RU |
dc.subject | genetic polymorphism | ru_RU |
dc.subject | lipid profile | ru_RU |
dc.subject | left ventricle hypertrophy | ru_RU |
dc.subject | артеріальна гіпертензія | ru_RU |
dc.subject | генетичний поліморфізм | ru_RU |
dc.subject | ліпідний профіль | ru_RU |
dc.subject | гіпертрофія лівого шлуночка | ru_RU |
dc.subject | артериальная гипертензия | ru_RU |
dc.subject | генетический полиморфизм | ru_RU |
dc.subject | липидный профиль | ru_RU |
dc.subject | гипертрофия левого желудочка | ru_RU |
dc.title | Pathogenetic connection of lipid profile changes with left ventricle hypertrophic models depending on genes polymorphism' ace (I/D), eNOS (T894G) in patients with essential hypertension | ru_RU |
dc.type | Article | ru_RU |
Appears in Collections: | Статті. Кафедра гігієни та екології |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.